Laurus Labs Limited, one of India’s leading pharmaceutical and biotechnology companies, has established itself as a strong player in the global healthcare industry. Known for its expertise in Active Pharmaceutical Ingredients (APIs), formulations, and contract research and manufacturing services (CRAMS), the company continues to expand its footprint across international markets.
With a focus on innovation, cost efficiency, and sustainable growth, Laurus Labs is expected to witness consistent performance in the coming years. Investors are showing increasing interest in Laurus Labs shares as the company continues to strengthen its research pipeline and diversify its portfolio.
Laurus Labs Share Price Target 2026
Laurus Labs Limited, a leading pharmaceutical and biotechnology company in India, continues to gain investor confidence with its strong presence in the active pharmaceutical ingredients (API), formulations, and synthesis segments.
The company’s focus on innovation, cost efficiency, and capacity expansion has positioned it well for future growth. With increasing demand for APIs and contract manufacturing services globally, Laurus Labs is expected to deliver steady revenue and profit growth in the coming years.
Based on current market trends and analyst projections, the Laurus Labs share price target for 2026 is expected to range between ₹1100 and ₹1200, reflecting optimism about the company’s long-term performance and its ability to capitalize on expanding opportunities in the healthcare sector.
Laurus Labs Share Price Target 2026 Table
| Year | Laurus Labs Share Price Target 2026 |
|---|---|
| First Target 2026 | Rs 1100 |
| Second Target 2026 | Rs 1200 |
Laurus Labs Share Price Target 2027
Laurus Labs Limited, a leading pharmaceutical and biotechnology company in India, continues to gain investor attention due to its strong presence in APIs, formulations, and contract development and manufacturing (CDMO) services.
With a growing focus on innovation, cost efficiency, and expansion into global markets, the company is expected to deliver consistent growth over the next few years.
Analysts project that the Laurus Labs share price target for 2027 could be around ₹1300 to ₹1400, reflecting the company’s strong financial performance, expansion in high-margin segments, and increasing global demand for quality pharmaceuticals. If Laurus Labs maintains its growth momentum and enhances its product pipeline, it may achieve the higher end of this target range by 2027.
Laurus Labs Share Price Target 2027 Table
| Year | Laurus Labs Share Price Target 2027 |
|---|---|
| First Target 2027 | Rs 1300 |
| Second Target 2027 | Rs 1400 |
Laurus Labs Share Price Target 2028
Laurus Labs Limited, a leading pharmaceutical and biotechnology company in India, continues to strengthen its position in the global market through innovation, capacity expansion, and a strong product portfolio in APIs, formulations, and contract manufacturing.
The company’s focus on research-driven growth and diversification into high-value segments such as biotechnology and synthesis has attracted positive attention from investors.
Considering its strong fundamentals and improving margins, analysts project that the Laurus Labs share price target for 2028 could range between ₹1500 and ₹1600, reflecting steady growth potential supported by rising global demand for affordable and high-quality medicines.
Laurus Labs Share Price Target 2028 Table
| Year | Laurus Labs Share Price Target 2028 |
|---|---|
| First Target 2028 | Rs 1500 |
| Second Target 2028 | Rs 1600 |
Laurus Labs Share Price Target 2029
Laurus Labs Limited, a leading pharmaceutical and biotechnology company in India, continues to strengthen its position in the global market through innovation, expansion, and strategic partnerships.
With a strong presence in APIs, formulations, and contract research and manufacturing services (CRAMS), the company is expected to witness steady growth in the coming years. Backed by rising demand for life-saving drugs and a diversified product portfolio, Laurus Labs is poised for long-term success.
Based on current market trends and analyst projections, the Laurus Labs share price target for 2029 is expected to be ₹1700 on the lower side and could reach up to ₹1800 in a bullish scenario, reflecting strong fundamentals and consistent financial performance.
Laurus Labs Share Price Target 2029 Table
| Year | Laurus Labs Share Price Target 2029 |
|---|---|
| First Target 2029 | Rs 1700 |
| Second Target 2029 | Rs 1800 |
Laurus Labs Share Price Target 2030
Laurus Labs Limited, a leading pharmaceutical and biotechnology company in India, continues to demonstrate strong growth potential driven by its focus on Active Pharmaceutical Ingredients (APIs), formulations, and contract research and manufacturing services (CRAMS).
With consistent expansion in global markets and investments in innovation and sustainability, Laurus Labs is well-positioned for long-term success. Analysts predict that by 2030, the Laurus Labs share price target could reach between ₹1900 and ₹2100, depending on the company’s revenue growth, profit margins, and global demand for its products.
As Laurus Labs continues to diversify its product portfolio and strengthen its research capabilities, it remains a promising stock for long-term investors looking to benefit from the growth of India’s healthcare and pharma sectors.
Laurus Labs Share Price Target 2030 Table
| Year | Laurus Labs Share Price Target 2030 |
|---|---|
| First Target 2030 | Rs 1900 |
| Second Target 2030 | Rs 2100 |
Questions related to Laurus Labs Share F.A.Q.
– भविष्य के लिहाज से Laurus Labs का शेयर कैसा रहेगा?
जिस तरह से Laurus Labs अपने मजबूत आरएंडडी के साथ लगातार अपनी प्रत्येक श्रेणी में एक नया उत्पाद विकसित कर रही है और तेजी से उसे बाजार में उतार रही है, उसके कारण कंपनी के पास भविष्य के दृष्टिकोण से अपने व्यवसाय में वृद्धि करने का एक शानदार अवसर है।
– Laurus Labs शेयर में निवेश करना कब सही है?
जब भी आप Laurus Labs शेयरों में थोड़ा मंदी का माहौल देखते हैं, तो आप प्रत्येक गिरावट का फायदा उठाना चाहेंगे और लंबी अवधि के लिए छोटी मात्रा में निवेश करना चाहेंगे।
– Laurus Labs कंपनी के सीईओ अब कौन हैं?
सत्यनारायण चावा वर्तमान में Laurus Labs कंपनी के सीईओ के रूप में कार्यरत हैं।
Conclusion
In conclusion, Laurus Labs stands out as a strong long-term investment opportunity in the Indian pharmaceutical sector. The company’s strategic focus on innovation, operational efficiency, and global market expansion positions it well for sustained growth. Based on current market trends and future projections, analysts expect Laurus Labs’ share price to show steady upward momentum through 2026 to 2030.
Investors with a long-term perspective could benefit significantly as Laurus Labs continues to deliver strong financial results and expand its presence in both domestic and international markets.
Also read:-